Try our Advanced Search for more refined results
Intellectual Property
-
December 05, 2024
NCAA's NIL Settlement 'Illegal' In Many States, Lawmakers Say
The National Collegiate Athletic Association's $2.78 billion settlement with athletes over name, image and likeness compensation, now awaiting final court approval, would be "illegal" in several states because of their current NIL laws, a group of current and former lawmakers said Thursday.
-
December 05, 2024
Fed. Circ. Unlikely To Help Realtek Pursue ITC Sanctions
A Federal Circuit panel seemed baffled Thursday as a K&L Gates attorney argued that the U.S. International Trade Commission wrongly stopped his client from pursuing sanctions, with the panel repeatedly noting that the semiconductor company wasn't even a party in the import dispute.
-
December 05, 2024
9th Circ. Skeptical Starz Ripped Off Play For Strip Club Drama
A Ninth Circuit panel appeared dubious Thursday of a playwright's bid to revive claims that Starz Entertainment copied her stage musical for the strip club drama series "P-Valley," with one of the appellate judges noting that the works "could not be more different."
-
December 05, 2024
PrizePicks Faces Second Claim Of Fantasy Platform Ripoff
Atlanta-based sports betting platform PrizePicks has been hit with a second lawsuit in as many years from business-to-business sports tech company Vetnos, claiming Wednesday that PrizePicks ripped off its concept of daily fantasy betting games with the help of a former Vetnos employee.
-
December 05, 2024
Skadden Adds A&O Shearman IP Litigator In Silicon Valley
Skadden Arps Slate Meagher & Flom LLP continues expanding its technology team, announcing Thursday it has brought in an Allen Overy Shearman Sterling intellectual property litigator as a partner in its Silicon Valley office.
-
December 05, 2024
Fed. Circ. Backs Mixed PTAB Ruling In Circuit Patent Fight
The Federal Circuit on Thursday affirmed the Patent Trial and Appeal Board's finding that Dutch semiconductor maker NXP was able to show that some claims in a pair of Bell Semiconductor circuit patents were invalid but was unable to prove other claims were unpatentable.
-
December 05, 2024
Insulet Wins $452M In Trade Secret Theft Trial
A Massachusetts federal jury has awarded Insulet Corp. $452 million after concluding that a South Korean company stole its trade secrets for a wearable insulin patch pump, marking one of the largest trade secrets verdicts of the decade.
-
December 04, 2024
Withers IP Partners Hop To Sullivan & Worcester
Sullivan & Worcester LLP has said the Boston firm picked up a team of five intellectual property lawyers, including two partners, from Withers who have expertise in filing patents and working on deals for biotech startups.
-
December 04, 2024
Intel, VLSI Agree To Pause Del. IP Fight Ahead Of Texas Trial
Prodded by a federal judge in Delaware, Intel Corp. and VLSI Technology LLC agreed Wednesday to stay motions to dismiss or transfer an Intel Corp. suit over claims that it already holds licenses to patents that VLSI asserts it controls, as a similar patent battle moves forward in Texas.
-
December 04, 2024
Fed. Circ. Sinks Patent Fight Over Intel's CPU Chips
The Federal Circuit on Wednesday rubber-stamped a ruling out of Delaware federal court that cleared Intel of allegations that the chipmaker infringed patents by a University of Maryland professor who purportedly developed an important idea in the world of "parallel computing" in 2006.
-
December 04, 2024
Novartis Fails To Stop Generic Drug Release At Fed. Circ.
Novartis could not persuade Federal Circuit judges to grant an injunction Wednesday protecting its blockbuster heart failure medication from facing generic competition, with the appeals court backing a Delaware federal judge's opinion that it was unlikely that one of the generic drug's ingredients is "amorphous."
-
December 04, 2024
JSR Wins As Fed. Circ. Axes Cytiva Antibody Isolation Patents
In a precedential opinion, the Federal Circuit held Wednesday that all the claims that JSR Corp. challenged in three Cytiva Bioprocess antibody isolation patents are invalid as obvious, backing the Patent Trial and Appeal Board's invalidation of many claims while reversing its decision to uphold others.
-
December 04, 2024
Meta Persuades PTAB To Ax 2 Earphone Patents
The Patent Trial and Appeal Board has found that Meta was able to show that every claim in a pair of earphone patents owned by Eight kHz is invalid, holding they are obvious.
-
December 04, 2024
Fed. Circ. Sends UC System LED Patent Claims Back To PTAB
The Federal Circuit on Wednesday found that the Patent Trial and Appeal Board has to partially rethink its finding that claims in a filament LED light bulb patent owned by the University of California system were too obvious to warrant patent protection.
-
December 04, 2024
Penn State Eyes Ban, Atty Fees After Trial Win Against Retailer
The Pennsylvania State University has asked a federal court in the Keystone State to permanently block an online retailer and its owner from selling merchandise that a jury found infringed the university's trademarks, and said it is entitled to attorney fees from the "serial infringers."
-
December 04, 2024
Fleetwood Mac Producer, Playwright Settle IP Dispute
A producer of the 1977 Fleetwood Mac album "Rumours" and the author of the play "Stereophonic" have resolved claims that the Broadway show infringed copyrighted material from a memoir about making the record, according to a filing in New York federal court.
-
December 04, 2024
Amazon, Stanley Tumbler Maker Sue Alleged Counterfeiters
Amazon and the maker of the popular "Stanley" tumbler are suing several marketplace vendors in Washington federal court, accusing them of peddling counterfeit drink ware in the e-commerce platform's latest legal push to crack down on brand-stealing sellers.
-
December 04, 2024
Ace Hardware Looks To Nail Screw-Selling Rival Over TM Use
Ace Hardware Corp. said Tuesday that a home improvement chain sharing the Ace name is watering down its decades of name recognition and goodwill while creeping in on Ace's turf and leading confused consumers astray.
-
December 04, 2024
Fed. Circ. Judge Condemns 'Nonsense' Law In Antibody Fight
U.S. Circuit Judge Todd Hughes called the Federal Circuit's case law on interpreting preambles in patent claims "nonsense" on Wednesday, expressing frustration as a panel tried to work through whether Xencor Inc.'s antibody patent application was too broad.
-
December 04, 2024
Fed. Circ. Backs NY Judge In Freeing Meta From Patent Suit
The Federal Circuit on Wednesday wouldn't revive a software company's suit claiming Meta Platforms Inc. infringed patents on digital data storage and organization, agreeing with a decision that the evidence couldn't back a finding that the Meta features at issue covered all parts of the patent claims.
-
December 03, 2024
Samsung Foe Wants More Money After $192M Patent Win
A small Silicon Valley outfit that makes wireless chargers wants U.S. District Judge Rodney Gilstrap to potentially triple the $192 million willful infringement verdict the company won against Samsung, citing the smartphone maker's "egregious" conduct during trial in Texas federal court in Marshall.
-
December 03, 2024
Wheeling & Appealing: The Latest Must-Know Appellate Action
December's appellate forecast calls for a squall of showdowns in a tiny time period before the holidays, including arguments involving recent U.S. Supreme Court cases, Big Tech's patents and popular purveyors of health food. In addition, winds of change are swirling around the White House's litigation posture and judicial nominations, and we'll quiz you on the latter in this edition of Wheeling & Appealing.
-
December 03, 2024
Bearing Maker Settles With RTX, Rival In Trade Secrets Case
A Connecticut roller bearing company has settled its lawsuits accusing military supplier RTX and a competitor of misusing trade secrets related to the design of a U.S. military bomb, after earlier delays in reaching an agreement.
-
December 03, 2024
Meta, Jawbone Strike Deal Ending VR Headset Patent Case
Meta Inc. said Tuesday it has reached a settlement with Jawbone Innovations to end a lawsuit in Texas federal court claiming its virtual reality headsets infringe a series of Jawbone's patents.
-
December 03, 2024
USPTO Abandons Polarizing Proposal Over Double Patenting
The U.S. Patent and Trademark Office has withdrawn an extremely controversial proposal tied to double patenting, citing "resource constraints" in a Federal Register notice set to be published Wednesday.
Expert Analysis
-
USPTO Must Anticipate 'Black-Box Problem' For AI Inventions
The U.S. Patent and Trademark Office's recent guidance allows patents for inventions created with artificial intelligence, but inventors need to address the so-called black-box problem to ensure others can recreate the invention, thus meeting the enablement requirement, say Mark Basanta and Georg Reitboeck at Haug Partners.
-
Irish Businesses Should Act Now To Prepare For EU AI Act
Artificial intelligence is increasingly transforming the Irish job market, and proactive engagement with the forthcoming European Union AI Act, a significant shift in the regulatory landscape for Irish businesses, will be essential for Irish businesses to responsibly harness AI’s advantages and to maintain legal compliance, say lawyers at Pinsent Masons.
-
How To Grow Marketing, Biz Dev Teams In A Tight Market
Faced with fierce competition and rising operating costs, firms are feeling the pressure to build a well-oiled marketing and business development team that supports strategic priorities, but they’ll need to be flexible and creative given a tight talent market, says Ben Curle at Ambition.
-
Considerations For Federal Right Of Publicity As AI Advances
Amid rapid advances in generative artificial intelligence technology, Congress should consider how a federal right of publicity would interact with the existing patchwork of state name, image and likeness laws, as well as other issues like scope, harm recognized and available relief, says Ross Bagley at Pryor Cashman.
-
What Patent Litigators Should Know About CHIPS Act Grants
With the U.S. Department of Commerce now actively awarding grants under the CHIPS and Science Act, recipients should ensure they understand the implications of promises to construct new semiconductor manufacturing facilities, especially in jurisdictions with active patent litigation dockets, say Gabriel Culver and Peter Hillegas at Norton Rose.
-
Patent Lessons From 5 Federal Circuit Reversals In June
A look at June cases where the Federal Circuit reversed or vacated decisions by the Patent Trial and Appeal Board or a federal district court highlights a potential path for branded drugmakers to sue generic-drug makers for off-label uses, potential downsides of violating a pretrial order offering testimony, and more, say Denise De Mory and Li Guo at Bunsow De Mory.
-
Series
Rock Climbing Makes Me A Better Lawyer
Rock climbing requires problem-solving, focus, risk management and resilience, skills that are also invaluable assets in my role as a finance lawyer, says Mei Zhang at Haynes and Boone.
-
Think Like A Lawyer: Dance The Legal Standard Two-Step
From rookie brief writers to Chief Justice John Roberts, lawyers should master the legal standard two-step — framing the governing standard at the outset, and clarifying why they meet that standard — which has benefits for both the drafter and reader, says Luke Andrews at Poole Huffman.
-
Alice Step 2 Trends Show Courts' Extrinsic Evidence Reliance
A look at recent trends in how district courts are applying Step 2 of the Alice framework shows that courts have increasingly relied on extrinsic evidence to help determine whether a claimed invention is "well-understood, routine, and conventional," says Jonathan Tuminaro at Sterne Kessler.
-
Recent Settlement Shows 'China Initiative' Has Life After Death
Though the U.S. Department of Justice shuttered its controversial China Initiative two years ago, its recent False Claims Act settlement with the Cleveland Clinic Foundation demonstrates that prosecutors are more than willing to civilly pursue research institutions whose employees were previously targeted, say attorneys at Benesch.
-
How Orange Book Antitrust Scrutiny Is Intensifying
Pharmaceutical patent holders should be reviewing Orange Book listing practices, as the Federal Trade Commission takes a more aggressive antitrust approach with actions such as the Teva listing probe, and the U.S. Food and Drug Administration calls attention to potentially improper listings, say attorneys at McDermott.
-
Trending At The PTAB: 1 Year Of Denials Of Institution
An analysis of Patent Trial and Appeal Board denials of institutions between May 2023 and May of this year highlights the board’s common reasons for denial, which can provide insight to both petitioners and patent owners in future proceedings, say Kevin Rodkey and Victor Palace at Finnegan.
-
Questions Linger About DTSA's Scope After Motorola Ruling
The Seventh Circuit’s recent ruling in Motorola v. Hytera, which held that the Defend Trade Secrets Act applies extraterritorially, does not address whether an act that furthers misappropriation must be committed by the defendant in order to satisfy the law's extraterritoriality requirement, say Ilissa Samplin and Grace Hart at Gibson Dunn.
-
Opinion
Conception Is The Proper Test For AI-Assisted Inventions
The U.S. Patent and Trademark Office should adopt the conception standard for reviewing AI-assisted inventions, and require the disclosure of artificial intelligence prompts and responses because they are material to patentability, which would then simplify the patent examiner’s invention decision, says Thomas Hamlin at Robins Kaplan.
-
What High Court TM Rulings Tell Us About Free Speech
Recent U.S. Supreme Court rulings show tension between free speech and trademark law, highlighting that while political mockery is protected, established brands may be forced to adapt to evolving cultural values, says William Scott Goldman at Goldman Law Group.